Relmada Therapeutics, Inc
Fundamentals
Oldest to newest| Line | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | Jun 2026 |
|---|---|---|---|---|---|
| Operating income | −$161.2M | −$103.7M | −$83.9M | −$59.1M | none on file |
| Net income | −$157.0M | −$98.8M | −$80.0M | −$57.4M | none on file |
| Operating cash flow | −$103.8M | −$51.7M | −$51.8M | −$45.8M | none on file |
| Cash | $5.4M | $4.1M | $3.9M | $3.5M | $11.3M |
| Shares outstanding | 30.1M | 30.1M | 30.2M | 73.3M | 106.7M |